首页> 外文期刊>AIDS Research and Human Retroviruses >Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.
【24h】

Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.

机译:说起来容易做起来难:世界卫生组织关于预防艾滋病毒关注的母婴传播的建议。

获取原文
获取原文并翻译 | 示例
           

摘要

The World Health Organization released recommendations on treatment, prevention, and infant feeding practices within the context of HIV infection based on the latest scientific evidence the release of official HIV Prevention-of-Mother-to-Child Transmission guidelines. As investigators involved in public health programs providing HIV care in sub-Saharan Africa, we are concerned about the ramifications of specific recommendations, often viewed as dogma by policy makers in this setting. The recommendation that CD4 cell counts be available antenatally so that decisions can be made regarding maternal antiretroviral eligibility is problematic because the ability to measure CD4 cells is nonexistent in many African health centers. As a result, antiretroviral treatment initiation in pregnancy will either be unnecessarily delayed or patients in need of treatment may receive prolonged courses of monotherapy. It is critical that exceptions be made for populations without access to flow cytometry. Another point of concern is that the massive unrestricted use of efavirenz during pregnancy is encouraged. Given that surveillance of pregnancy outcomes is not routinely performed in such settings and in light of the teratogenic potential of efavirenz (contraindicated during the first trimester in developed countries), we are concerned that its indiscriminate use will lead to further problems in vulnerable populations. Another premature recommendation is the use of daily administration of nevirapine to HIV-exposed infants throughout the entire duration of breastfeeding. Results of clinical trials documenting the efficacy of this approach for extended periods of time are not yet available. Single dose nevirapine has been shown to compromise future treatment options in HIV-infected women and infants. In addition, the long-term safety profile of this agent in immune-competent infants has not been established. In summary, although the guidelines do underscore major advances in the field, specific caveats are not yet supported by existing data.
机译:世界卫生组织根据最新的科学证据发布了正式的艾滋病毒母婴传播指导原则,发布了有关艾滋病毒感染情况下的治疗,预防和婴儿喂养方法的建议。作为参与在撒哈拉以南非洲提供艾滋病毒护理的公共卫生计划的调查员,我们对具体建议的后果感到担忧,在这种情况下,决策者通常将其视为教条。关于CD4细胞计数可以在产前获得的建议,以便就母亲的抗逆转录病毒资格进行决策,这是有问题的,因为在许多非洲卫生中心都不存在测量CD4细胞的能力。结果,妊娠中抗逆转录病毒治疗的启动将不必要地延迟,或者需要治疗的患者可能会接受较长的单一疗法疗程。对于无法使用流式细胞仪的人群,必须设置例外。另一个值得关注的问题是,鼓励在怀孕期间无限制使用依非韦伦。鉴于在这种情况下并没有常规监测妊娠结局,而且依非韦伦具有致畸性(在发达国家,孕早期已禁用),因此,我们担心,滥用依非韦伦将导致脆弱人群进一步面临问题。另一个过早的建议是在整个母乳喂养期间,每天向感染HIV的婴儿每天服用奈韦拉平。尚无证明该方法长期有效的临床试验结果。已显示单剂量奈韦拉平会在感染艾滋病毒的妇女和婴儿中影响未来的治疗选择。另外,尚未确定该剂在具有免疫能力的婴儿中的长期安全性。总而言之,尽管指南确实强调了该领域的重大进展,但现有数据尚不支持特定的警告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号